All
Shorter Radiation Courses May Improve Breast Reconstruction Outcomes
Shorter radiation courses may improve breast reconstruction outcomes without increasing complications, according to Dr. Reshma Jagsi.
How ‘Man in the Mirror’ Reflects a Cancer Journey
I always wanted to make a difference, but I never expected my biggest impact to come through cancer.
BELLA Clinical Trial Initiated in Platinum-Resistant Ovarian Cancer
The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ovarian cancer has been launched.
How Biomarker Testing Can Shape a Breast Cancer Treatment Plan
Biomarkers can shape a breast cancer treatment plan, Andy Guinigundo explained in an interview with CURE.
Raising Awareness for Lymphedema Following a Cancer Diagnosis
Dr. Sheri Yolanda Prentiss explores the challenges patients face in accessing lymphedema compression garments following cancer treatment.
FDA Grants HLX22 Orphan Drug Designation for Gastric Cancer
FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free survival and objective response.
Colorectal Cancer on Rise in Young Adults, Answers May Be Years Away
Colorectal cancer is on the rise among younger adults, although potential explanations for the cause of this trend are likely years away.
Personalized Cancer Vaccine Generates Responses Across Cancer Types
PGV001, a personalized cancer vaccine, induced immune responses across various cancer types like breast and urothelial cancer, as well as multiple myeloma.
Understanding the Use of Bispecific Antibodies in Multiple Myeloma
Bispecific antibodies target specific cells, offering effective treatment for relapsed/refractory multiple myeloma, with varying side effect profiles.
How Personalized Medicine May Impact Gastrointestinal Cancer Treatment
Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.
Overcoming Challenges and Advancing CAR-T Therapy for Myeloma
CAR-T therapy for myeloma faces challenges in early-line use due to accessibility, eligibility criteria and long wait times, despite strong efficacy in trials.
The Miniature Zen Garden: A Useful Tool for Those Dealing with Cancer
I tried using a Zen garden that helped me meditate and relax while dealing with the challenges of cancer, and it really works.
FDA Grants Breakthrough Therapy to IDE196 in Primary Uveal Melanoma
The FDA granted Breakthrough Therapy designation to IDE196 for the neoadjuvant treatment of primary uveal melanoma when enucleation has been recommended.
FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer
The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type of brain cancer.
Machine Learning Improves Transplant Risk Assessment in Myelofibrosis
Machine learning model improves transplant risk assessment for patients with myelofibrosis, helping clinicians make informed decisions, as per an expert.
Are You Worried About HER2+ Breast Cancer Recurrence?
Survey Findings Reveal Financial Challenges in Patients with Cancer
Among patients with cancer, high out-of-pocket costs were found to impact access to health care, adherence to medication, as well as quality of life.
Breaking Down Kidney Cancer Treatment Advancements and Providing Hope
Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease.
Breaking Down Early Signs and Symptoms of Head and Neck Cancer
April is Head and Neck Cancer Awareness Month, and it is important to be aware of early signs and symptoms of the disease, as well as when to seek care.
How Breast Cancer Taught Me Resilience in Unexpected Life Challenges
Lessons I learned from a cancer diagnosis have been applied in some surprising and seemingly unrelated aspects of my life.
NG-350A Evaluated in FORTRESS Trial for Locally Advanced Rectal Cancer
The first patient with locally advanced rectal cancer has been enrolled in the FORTRESS study which is evaluating the investigative immunotherapy NG-350A.
Investigative Agent Elicits Responses in Phase 3 Breast Cancer Trial
Immune response data from FLAMINGO-01 shows positive results in patients with HER2+ breast cancer, suggesting potential for further treatment expansion.
Development of Nemvaleukin for Platinum-Resistant Ovarian Cancer Halted
A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on to final analysis.
FDA Approves Initiation of a New Trial in Recurrent Glioblastoma
The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a form of brain cancer.
The Benefit of Clinical Trial Enrollment for Patients With Cancer
There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.
Addressing Gaps, Challenges and Disparities in AYA Cancer Care
Adolescent and young adult patients with cancer face delayed diagnoses, financial hardships and gaps in specialized care, creating a need for tailored support.
Unexpected Challenges 11 Years After Breast Cancer
Eleven years post diagnosis and issues related to breast cancer still frustrate me.
Camrelizumab Combo Doubles 5-Year Survival in Phase 3 Lung Cancer Trial
Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a Phase 3 trial.
A New Comprehensive Hereditary Cancer Solution Has Been Launched
A new comprehensive hereditary cancer solution offers genetic counseling and multigene panels to enhance early detection of disease's like brain cancer.
NeuroSAFE Increases Erectile Function After Prostate Cancer Surgery
Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.
